Jul 23, 2026 07:12AM

Jul 22, 2026 08:02AM

Jul 22, 2026 08:00AM

Jul 20, 2026 08:00AM

Jul 20, 2026 08:00AM

Jun 30, 2026 08:00AM

Jun 30, 2026 08:00AM Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation for ALXN1840 for the Treatment of Wilson Disease

Jun 30, 2026 06:05AM

Jun 26, 2026 04:05PM

Jun 26, 2026 04:05PM

May 14, 2026 02:00PM

Apr 21, 2026 08:52AM

Apr 19, 2026 07:00PM

Apr 19, 2026 07:00PM Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026

Mar 30, 2026 05:08AM

Mar 27, 2026 04:37PM

Mar 27, 2026 04:30PM

Mar 27, 2026 01:00PM

Mar 2, 2026 08:04AM

Mar 2, 2026 08:00AM

Jan 21, 2026 06:56AM Monopar Therapeutics (MNPR) Reiterated at Overweight by Cantor Fitzgerald: On Track

Jan 14, 2026 04:23AM

Jan 7, 2026 01:17PM

Nov 13, 2025 08:00AM

Oct 13, 2025 05:30AM

Oct 10, 2025 07:24AM

Oct 6, 2025 05:31AM

Sep 24, 2025 03:53PM Monopar Therapeutics (MNPR) PT Raised to $104 at BTIG

Sep 9, 2025 08:12AM

Aug 12, 2025 08:00AM

Jun 23, 2025 05:03AM

Jun 11, 2025 07:00AM

May 13, 2025 08:00AM

Mar 31, 2025 08:00AM

Mar 19, 2025 04:20AM Piper Sandler Assumes Monopar Therapeutics (MNPR) at Overweight

Nov 11, 2024 07:25AM

Nov 8, 2024 08:00AM

Jun 1, 2023 07:00AM

Jun 1, 2023 07:00AM

Mar 27, 2023 05:02PM

Mar 27, 2023 05:00PM

Mar 27, 2023 05:00PM Monopar Announces Result of Interim Analysis of Phase 2b/3 VOICE Trial Evaluating Validive for Severe Oral Mucositis

Oct 5, 2022 08:00AM

Oct 5, 2022 08:00AM

Mar 24, 2022 08:00AM

Mar 24, 2022 08:00AM

Feb 15, 2022 08:05AM

Feb 15, 2022 08:05AM

Feb 15, 2022 08:05AM Monopar Announces Clinical and Preclinical Program Updates

Nov 12, 2021 08:00AM

326,513 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All